(Source: Epizyme Inc) CAMBRIDGE, Mass., July 1, 2013/PRNewswire-USNewswire/ -- Epizyme, Inc., (NASDAQ: EPZM) a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the Company has been added to the Russell2000®,...
↧
